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ABSTRACT  Splenic involvement of an infected pseudocyst is known to be a rare 
complication of infected pancreatic necrosis following pancreatitis. We present herein a case of 
chronic alcoholic pancreatitis complicated by a major infected pseudocyst formation involving 
the spleen, with subsequent rupture and complete disappearance of the entire spleen. A 
60-year-old Japanese man with a history of chronic alcoholic pancreatitis with a pancreatic 
tail pseudocyst was referred to us because of severe epigastralgia. CT revealed spontaneous 
rupture of the pseudocyst into the stomach and free air in the pseudocyst. The body and tail 
of the pancreas were disrupted due to pancreatic necrosis, and the splenic parenchyma was 
also partially ruptured and disrupted with large tears of the splenic surface. One month later, 
CT showed almost complete disruption of the splenic parenchyma. Three months later, CT 
showed remarkable regression of the pseudocyst and complete disappearance of the entire 
spleen. Although splenic involvement of pancreatic pseudocysts should be considered to 
be a potentially lethal complication because of hemorrhage or infection, it can possibly be 
treated conservatively. In the present case, complete obstruction of both the splenic artery and 
vein due to chronic inflammation, and spontaneous drainage into the stomach were the most 
probable causes for the spontaneous regression without surgical treatment. This is the first 
report of splenic disappearance after splenic rupture demonstrated by CT.
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INTRODUCTION 
   Splenic involvement of an infected pseudocyst is 
an uncommon complication of infected pancreatic 
necrosis following acute or chronic pancreatitis, 
and may include intrasplenic pseudocyst, abscess, 
hemorrhage, infarction, splenic rupture, and 
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vascular injury. Because these complications can be 
potentially life-threatening, the course of the disease 
should be closely monitored by helical computed 
tomography (CT) or ultrasonography (US) to 
determine when surgical intervention is necessary 
[1]. We present herein a case of chronic alcoholic 
pancreatitis complicated by a huge infected 
pseudocyst formation involving the spleen, with 
subsequent rupture and disappearance of the spleen. 
This is the first report of splenic disappearance after 
splenic rupture demonstrated by CT.
CASE REPORT
   A 60-year-old Japanese man with seven year 
history of chronic alcoholic pancreatitis with a 
pancreatic tail pseudocyst was referred to us because 
of severe epigastralgia. Multiple pseudocysts in 
the tail of the pancreas were demonstrated on 
contrast-enhanced (CE) CT 5 years before (Fig.1). 
His arterial blood pressure was 188/100 mmHg, 
his white blood cell count was 18100/mm3 and 
serum amylase was 168 IU/L (normal range, 
40–118 IU/L). He was diagnosed as being in an 
acute relapsing phase of chronic pancreatitis. After 
admission, emergency CT revealed an enlarged 
pseudocyst in the tail of the pancreas which directly 
extended into the splenic parenchyma (Fig.2). It 
was recommended to undergo surgical treatment. 
However, he rejected invasive treatments such 





pseudocyst into the stomach and free air in the pseudocyst. Fig. 3b. The body and tail of the pancreas were disrupted due to pancreatic 
necrosis, and the splenic parenchyma was also partially ruptured and 




Fig. 1.　Five years before, multiple pseudocysts in the tail of 
the pancreas were demonstrated on CE-CT (arrows).
Fig. .　After 10 days, CE-CT showed spontaneous 
rupture of the pseudocyst into the stomach and free air in the 
pseudocyst.
Fig. 3b.　At a different level, the body and tail of the 
pancreas were disrupted due to pancreatic necrosis, and the 
splenic parenchyma was also artially ruptu ed and disrupted 
with large tears of the splenic surface (arrows).
Fig. 2.　On admission, eme gency CT revealed an enlarged 
pseudocyst in the tail of the pancreas which directly extended 
into the splenic parenchyma (arrow).
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reasons, although we informed the high mortality 
rate in a conservative treatment for that splenic 
complication. We considered endoscopic drainage 
or percutaneous drainage as an alternative treatment. 
In 2001, the endoscopic drainage was not popular 
and endoscopists in our institution did not have 
techniques to perform endoscopic drainage at 
that time. Also, percutaneous drainage could not 
be performed, because it could not avoid splenic 
injury. Fortunately, he was in stable condition and 
did not show any symptoms related to hemorrhagic 
complications. Medical treatment with gabexate 
mesilate and prophylactic antibiotics was continued 
and his symptoms gradually improved. Ten days 
later, CE-CT showed spontaneous rupture of the 
pseudocyst into the stomach and free air in the 
pseudocyst (Fig.3a). The body and tail of the 
pancreas were disrupted due to pancreatic necrosis, 
and the splenic parenchyma was also partially 
ruptured and disrupted with large tears of the 
splenic surface (Fig.3b). However, he still showed 
no hemorrhagic complications. One month later, 
CE-CT showed almost complete disruption of the 
splenic parenchyma (Fig.4). Three months later, CE-
CT showed remarkable regression of the pseudocyst 
and complete disappearance of the entire spleen 
(Fig.5). Four months later, he returned to his daily 
activities. More than three years after the event, the 
patient is alive and free from symptom.
DISCUSSION
   The incidence of splenic complications in patients 
with pancreatic pseudocysts has been reported to 
be 1 - 6%, and include intrasplenic pseudocyst, 
subcapsular hematoma, and splenic rupture1-4). A 
high complication rate of 79% and a high mortality 
rate of 8% have been reported and these high rates 
are an indication of the difficulties and complexities 
in treatment.
   Splenic rupture is one of the most serious 
compl i ca t ions  and  usua l ly  deve lops  a s  a 
consequence  of  in t rasp len ic  pseudocys ts . 
In t rasplenic  pseudocyst  i s  the  most  of ten 
complication in the spleen and a number of cases 
have been reported1,5,6). The incidence of intrasplenic 
pseudocysts in patients with chronic pancreatitis 
with distal pseudocysts has been reported to be 6 
%3). Ueda et al reviewed 27 cases of intrasplenic 
pseudocyst of which 6 cases (22.2%) developed 
complications including 2 cases of intracystic 
hemorrhage, 2 cases of splenic rupture (7.4%), and 2 
cases of infection6). Another review noted that 15 of 
42 cases (35.7%) of pancreatic pseudocyst involving 
the spleen developed hemorrhagic complications 
including 7 cases of intracystic hematoma, 6 cases 
of subcapsular hematoma, and 2 ruptures of the 
spleen (4.8%)7).
   Liquefaction of splenic infarcts, proteolytic 
effects of pancreatic enzymes on splenic vessels or 
Fig. 4.  One month later, CE-CT showed almost complete disruption 
of the splenic parenchyma. (arrows). Fig. 5. Three months later, CE-CT showed remarkable regression of 
the pseudocyst and disappearance of the spleen.
Fig. 4.　One month later, CE-CT showed almost complete 
disruption of the splenic parenchyma (arrows).
Fig. 5.　Three months later, CE-CT showed remarkable 
regression of the pseudocyst and disappearance of the spleen.
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parenchyma may present alternative mechanisms 
of development of intrasplenic pseudocysts3). A 
fistulous or inflammatory connection between the 
pancreatic tail and the spleen may also cause splenic 
complications. In addition, four pathogenetic 
mechanisms of splenic rupture associated with 
pancreatic pseudocysts have been suggested; (a) 
encasement of splenic vessels, causing infarction; 
(b) intrasplenic dissection of pancreatic enzymes, 
such as elastase and trypsin; (c) damage to small 
intrasplenic vessels causing intrasplenic or 
subcapsular hematoma; (d) If the hematoma is 
large enough, laceration, capsular disruption, or 
actual rupture of the spleen may occur4,8). Moreover, 
the presented case did not show any hemorrhagic 
complicat ions  including hemoperi toneum, 
hematemesis, or bleeding pseudocyst. This specific 
condition strongly suggests complete obstruction 
of both the splenic artery and vein due to extensive 
inflammation and compression around the vessels.
   The clinical consequences of involvement of 
the spleen and its vasculature include splenic vein 
thrombosis, arterial pseudoaneurysms, splenic 
infarction, splenic rupture, intra-abdominal 
bleeding, and death9). Splenic infarction resulting 
from obstruction of the splenic artery is a rare 
complication of pancreatitis. The probable causes 
of arterial constriction and obstruction have 
been reported to be pancreatic fibrosis around 
the artery, tortuous aneurysm, splenic vein 
thrombosis, compression by edematous pancreatitis, 
and chemical inflammation leading to arterial 
thrombosis10,11). The splenic artery courses along 
the pancreas within the anterior pararenal space and 
it is highly susceptible to the effects of pancreatic 
inflammation.
   Bernades  e t  a l  repor ted the  f indings  of 
splenoportal venous obstruction (SPVO) in 13.2 % 
of chronic pancreatitis cases12). Acute pancreatitis 
and pseudocysts were considered the probable 
causes of SPVO in 91.4 % of those cases and SPVO 
was found in 24.0 % of patients with previous 
acute pancreatitis and pseudocyst. The pathogenetic 
hypothesis of SPVO relates it to many factors: 
(a) venous constriction by fibrosis; (b) intimal 
injury and venous thrombosis; (c) extension of 
thrombosis13,14).
   CT and/or US are necessary in making a diagnosis 
of splenic complications and in looking for other 
risk factors including necrosis, abscess, bleeding 
in the cyst, hemoperitoneum, and splenic vein 
thrombosis. CT is the primary radiographic method 
of diagnosis. Earlier detection of complicated 
pseudocysts may contribute to a decreased number 
of patients presenting with acute life-threatening 
hemorrhage4). Care must be taken in dealing 
with high-risk pseudocysts involving the splenic 
parenchyma.
   The application of surgical treatment for splenic 
complications of pancreatic pseudocysts is 
controversial. Usually, in the case of the absence 
of spontaneous regression or expansion of the 
pseudocysts, a distal pancreatectomy with a 
splenectomy is recommended. Some investigators 
have suggested that surgery is mandatory and the 
only definitive treatment2,4,8). Percutaneous drainage 
has also been reported to be for intrasplenic 
pseudocysts15). However, recently the principles of 
treatment for pancreatic pseudocysts have become 
more conservative16,17). Rypens et al reported on 
12 of 16 patients with splenic complications who 
were conservatively and successfully managed18). 
They suggested that most splenic parenchymal 
complications of pancreatitis regress spontaneously 
and might be managed conservatively. In the 
present case, we did not perform surgery, because 
the patient rejected surgery and did not develop any 
serious complications such as hemoperitoneum or 
gastrointestinal bleeding. Conservatively, the huge 
pancreatic pseudocyst regressed after the rupture 
and disappearance of the spleen.
   Pancreatic pseudocyst drainage by endoscopy 
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has been employed with increasing frequency. 
In a retrospective study, surgical or endoscopic 
management resulted in similar success rates of 
50% and 52%, respectively, after an average period 
of 33 months follow up19). However, the majority 
of these patients had simple, uncomplicated 
pseudocysts. Recently, endoscopic treatment of 
more complicated pancreatic pseudocysts, including 
ductal disruption20), pancreatic necrosis, and 
pancreatic pseudoaneurysms21), has been reported. 
They utilized endoscopic transenteric drainage 
(endoscopic cysto-gastrostomy), endoscopic 
transpapillary drainage and stenting22). In the present 
case, we could not perform endoscopic drainage, 
unfortunately. However, if the endoscopic drainage 
for the pseudocyst had been performed earlier, 
disappearance of the spleen might not be happened.
   In conclusion, we reported a case of complete 
disappearance of the entire spleen after rupture due 
to involvement of a pancreatic pseudocyst which 
was treated without surgery. Although splenic 
involvement of pancreatic pseudocysts should be 
considered to be a potentially lethal complication 
because of hemorrhage or infection, it can possibly 
be treated conservatively. In the present case, 
complete obstruction of both the splenic artery and 
vein due to chronic inflammation, and spontaneous 
drainage into the stomach were considered the most 
probable causes for spontaneous regression without 
surgical treatment. However, if early treatments 
could have been done, those complications might 
not be happened.
DISCLOSURE STATEMENT
   None of the authors have any conflicts of interest 
to declare. This work was not funded by any 
educational or commercial organization.
REFERENCES
１） Patil PV, Khalil A, Thaha MA : Splenic parenchymal 
complications in pancreatitis. JOP 12 : 287-291, 2011
２） Fishman EK, Soyer P, Bliss DF, Bluemke DA, Devine N 
: Splenic involvement in pancreatitis : spectrum of CT 
findings. Am J Roentgenol 164 : 631-635, 1995
３） Malka D, Hammel P, Lévy P, Sauvanet A, Ruszniewski P, 
Belghiti J, Bernades P : Splenic complications in chronic 
pancreatitis : prevalence and risk factors in a medical – 
surgical series of 500 patients. Br J Surg 85 : 1645-1649, 
1998
４） Heider R, Behrns KE : Pancreatic pseudocysts 
complicated by splenic parencymal involvement : results 
of operative and percutaneous management. Pancreas 23 
: 20-25, 2001
５） Hatsuno T, Inoue S, Kaneko T, Kimata H, Yagi Y, Takeda 
S, Nakao A : A case of multiple pancreatic pseudocysts 
penetrating into the spleen. Nippon Shokakibyo Gakkai 
Zasshi 99 : 50-56, 2002
６） Ueda N, Takahashi N, Yamasaki H, Hirano K, Ueda K, 
Yoshida S, Tanino M, Gabata T : Intrasplenic pancreatic 
pseudocyst : a case report. Gastroenterol Jpn 27 : 675-
682, 1992
７） Yano T, Kaneda M, Yamamoto T, Suzuki T, Fujimori 
K, Itoh H : Pancreatic pseudocyst involving the spleen. 
Gastroenterol Jpn  23 : 73-77, 1988
８） Torricelli P, Coriani C, Marchetti M, Rossi A, Manenti A 
: Spontaneous rupture of the spleen : report of two cases. 
Abdom Imaging 26 : 290-293, 2001
９） Mauro MA, Schiebler ML, Parker LA, Jaques PF : The 
spleen and its vasculature in pancreatitis : CT findings. 
Am Surg 59 : 155-159, 1993
10） Belli AM, Jennings CM, Nakielny RA : Splenic and 
portal venous thrombosis : a vascular complication 
of pancreatic disease demonstrated on computed 
tomography. Clin Radiol 41 : 13-16, 1990
11） Rice PF, Khan MS, Mackle EJ : Total splenic infarction 
in acute pancreatitis. J R Coll Surg Edinb 41 : 54-56, 
1996
12） Bernades P, Baetz A, Lévy P, Belghiti J, Menu Y, Fékété 
F: Splenic and portal venous obstruction in chronic 
pancreatitis. A prospective longitudinal study of a 
medical-surgical series of 266 patients. Dig Dis Sci 37 : 
340-346, 1992
13） Warshaw AL, Jin GL, Ottinger LW : Recognition and 
clinical implications of mesenteric and portal vein 
obstruction in chronic pancreatitis. Arch Surg 122 : 410-
415, 1987
14） Bradley EL : The natural history of splenic vein 
78 Kawasaki Medical Journal
thrombosis due to chronic pancreatitis : indications for 
surgery. Int J Pancreatol 2 : 87-92, 1987
15） Tennøe B, Bay D, Rosales R.: Percutaneous drainage 
of intrasplenic pancreatic pseudocyst. Case report, Acta 
Radiol 37 : 195-197, 1996
16） Loveday BP, Mittal A, Phillips A, Windsor JA. : 
Minimally invasive management of pancreatic abscess, 
pseudocyst, and necrosis: a systematic review of current 
guidelines. World J Surg. 32 : 2383-2394, 2008
17） Dumonceau JM, Macias-Gomez C. : Endoscopic 
management of complications of chronic pancreatitis. 
World J Gastroenterol. 19 : 7308-7315, 2013
18） Rypens F, Deviére J, Zalcman M, Braudé P, de Stadt 
JV, Struyven J, Gansbeke DV : Splenic parencymal 
complications of pancreatitis : CT findings and natural 
history. J Computer Assisted Tomography 21 : 89-93, 
1997
19） Froeschle G, Meyer-Pannwitt U, Brueckner M, Henne-
Bruns D : A comparison between surgical, endoscopic 
and percutaneous management of pancreatic pseudocysts 
- long term results. Acta Chir Belg 93 : 102-106, 1993
20） Godil A, Chen YK : Endoscopic management of benign 
pancreatic disease. Pancreas 20 : 1-13, 2000
21） Elton E, Howell DA, Amberson SM, Dykes TA : 
Combined angiographic and endoscopic management 
of bleeding pancreatic pseudoaneurysms. Gastrointest 
Endosc 46: 544-549, 1997
22） Pitchumoni CS, Agarwal N : Pancreatic pseudocysts. 
When and how should drainage be performed? 
Gastroenterol Clin North Am. 28 : 615-639, 1999
